Wellnex Life (ASX/AIM: WNX) is pleased to announce its Half-Year Financial Report, ending 31 December 2025. View the full announcement 🔗 ap1.hubs.ly/y0DJLM0 📲 Stay up-to-date on company news and announcements: ap1.hubs.ly/y0DMqc0 #WellnessIndustry #MarketUpdate

Wellnex Life (ASX/AIM: WNX) is pleased to release an update for the quarter ending 31 December 2025. Ash Vesali will be hosting an Investor Briefing on 2nd February at 11am (AEDT). Register 👉 ap1.hubs.ly/y0xZP20 View announcement 🔗 ap1.hubs.ly/y0xZp-0

Wellnex Life $WNX is pleased to provide a trading update for the period January to April 2025. View 👉 hubs.ly/Q03m8LXm0 Wellnex continues to see growth across the whole business which the Board expects to continue for the remainder of FY25 and into FY26. #Health #Wellness

Wellnex Life $WNX announces that it has received initial conditional binding commitments through its Lead Brokers of A$9 million. View the announcement 👉 hubs.ly/Q036J0Jk0 #Health #Wellness #LSE

$WNX MD Zack Bozinovski with @StockheadAU Health & Biotech journalist Nadine McGrath, on the “Vital Signs" podcast👉 hubs.ly/Q035KyXs0 He discusses the company’s brand portfolio & game-changing partnerships, ahead of its plans to dual list on the London Stock Exchange.

Special Report 📣 Wellnex Life $WNX has achieved a key milestone with a new market authorisation by Australia’s Therapeutic Goods Administration for a liquid paracetamol plus caffeine soft gel. Read more @australian👉 hubs.ly/Q035wmxT0 #Health #Wellness

Wellnex Life $WNX is in the process of raising up to $16 million ahead of a secondary London listing, having transformed from a low-margin brand broker to an own-brand powerhouse. Read more, @australian 👉 hubs.ly/Q035wm6D0 #LSE #Wellness #Health #Haleon

📣 Wellnex Life $WNX is pleased to report record sales of $3 million per month for November and December 2024 with its dual listing on the LSE imminent. Read more 👉 hubs.ly/Q035884t0 🔗To stay up-to-date on company news: hubs.ly/Q0358fQT0 #Wellness #Health

Wellnex Life $WNX announces the approval of a new Market Authorisation (MA) for a liquid paracetamol plus caffeine soft gel, after the successful submission with TGA of the pharmaceutical dossier. View 👉 hubs.ly/Q0358bKS0 #Wellness #Health

$WNX MD Zack Bozinovski shares insights on why 2024 was a transformational year for the company, as we target a dual listing on the London Stock Exchange #LSE in early 2025👉 hubs.ly/Q0357tt00 🔗Stay up-to-date on company news: hubs.ly/Q0357s430 #Health #Wellness

Wellnex Life Limited $WNX is pleased to provide a company update for the July to December 2024 period, which included another strong month in December with sales of $3.02 million. View 👉 hubs.ly/Q031cqnb0 #Health #Wellness

Special Report: 📣 $WNX targets a dual listing on the London Stock Exchange (#LSE) early in the new year, with the company reporting its strongest November on record with sales of $3.16 million. Read more 👉 hubs.ly/Q02_cJMC0 #Wellness #Health

Wellnex Life $WNX is pleased to provide a company update for the July to November period, which included a record month in November with sales of $3.16 million. View 👉 hubs.ly/Q02-shQt0 #Health #Wellness

Wellnex Life $WNX is pleased to provide an update on the proposed dual listing on the main market of the London Stock Exchange (#LSE). View 👉 hubs.ly/Q02VB7N_0 #Health #Wellness

$WNX is pleased to announce the appointment of Mr George Tambassis as Non-executive Chair of Wellnex Life. View 👉 hubs.ly/Q02P3P0z0 Mr Tambassis has a long history of success in the consumer health and pharmaceutical market over a 35 year period. #Health #Wellness

Wellnex Life $WNX features in The Australian's ASX wellness stocks special report. Read more 👉 hubs.ly/Q02DkLZn0 @australian #Health #Wellness #NightyNight #MentalHealth

$WNX announces the launch of Wellness Life, a new medicinal cannabis brand will officially launch on 1 July 2024. View 👉 hubs.ly/Q02zNQ8N0 This marks a significant step in providing high-quality #MedicinalCannabis products to the burgeoning SAS-B market in Australia.

$WNX has successfully reintroduced the Pain Away brand through a strategic partnership with Chemist Warehouse New Zealand. View 👉 hubs.ly/Q02ym3k70 This reintroduction marks a significant step in Wellnex Life's export growth strategy for the #PainAway brand. #Health

Wellnex Life $WNX has commenced the process to dual list on the London Stock Exchange that will provide a pathway to accelerate our growth both domestically and internationally. View 👉 hubs.ly/Q02tK2vK0 #Health #Wellness #LSE